Back to company

ACUPHARMA ApS: Financial statements 2019

CVR: 10072956

ACUPHARMA ApS (CVR 10072956) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,684,289 and a net result of DKK 32,839 compared with DKK 5,216 the year before. That is a decrease of 2.3% compared with the year before. Equity amounted to DKK 386,805. The solvency ratio was 11.7%. The company had 4 employees in the financial year.

Gross Profit
1,684,289 kr.
Profit/Loss
32,839 kr.
Equity
386,805 kr.
Total Assets
3,292,250 kr.
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-1.7 mio.33 t.387 t.4
2018-1.7 mio.5 t.154 t.-
2017-1.5 mio.80 t.149 t.-
2016-1.1 mio.10568 t.-
2015-322 t.-360 t.68 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2019

ACUPHARMA ApS: The 2018 annual report is outMar 8, 2019

ACUPHARMA ApS has published its annual report for 2018. Gross profit came to DKK 1,724,257, and the net result was DKK 5,216.

About ACUPHARMA ApS

ACUPHARMA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Christina Uekermann Skive and Jeanne Helsted. The company is owned by SKIVE & HELSTED A/S. The company has 5 employees. In 2025, the company reported a gross profit of DKK 1,150,834 and a net result of DKK 287,572 compared with DKK -258,766 the year before. Equity amounted to DKK -109,301.